Endpoints News 6. Feb. 2026 Geoff McDonough's big plans for NodThera's NLRP3; Enhertu leader steps down at Daiichi
Endpoints News 6. Feb. 2026 Roivant spinout Priovant touts Phase 2 brepocitinib data in cutaneous sarcoidosis
Endpoints News 6. Feb. 2026 Illumina bets on healthcare after Trump administration's NIH funding disruptions
Endpoints News 5. Feb. 2026 #ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
Endpoints News 5. Feb. 2026 Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex